Infected thrombus in a Fontan circulation

Juan Francisco Fritche-Salazar1, Gabriela Meléndez-Ramírez2, José Antonio Arias-Godínez1

  • 1Echocardiography Department, National Institute of Cardiology Ignacio Chavez, Mexico City, Mexico.

Insights

The Fontan operation, a palliative treatment for single-ventricle heart defects, has poor long-term outcomes. Patients often develop complications like liver disease, heart failure, and arrhythmias within 10 years, requiring ongoing monitoring.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiovascular Surgery

Background:

  • The Fontan operation is a palliative surgical procedure for univentricular heart physiology, established in 1968.
  • Long-term outcomes following the Fontan operation are historically poor, with significant morbidity.
  • A substantial proportion of patients develop complications within a decade of the procedure.

Purpose of the Study:

  • To summarize the natural history and common complications associated with the Fontan operation.
  • To highlight the diagnostic modalities used for evaluating Fontan-associated morbidities.
  • To emphasize the importance of clinical and imaging follow-up in managing these patients.

Main Methods:

  • Review of the natural history and outcomes of patients undergoing the Fontan operation.
  • Identification of common complications, including tachyarrhythmias, liver disease, protein-losing enteropathy, heart failure, thrombosis, and infective endocarditis.
  • Discussion of diagnostic tools such as echocardiography and magnetic resonance imaging (MRI).

Main Results:

  • By 10 years post-Fontan operation, most patients experience at least one complication.
  • Complications encompass a wide spectrum, including cardiac, hepatic, gastrointestinal, and thromboembolic events.
  • Echocardiography and MRI are primary imaging techniques for complication detection.

Conclusions:

  • The Fontan operation, while life-extending, is associated with significant long-term complications.
  • Regular clinical assessment and advanced imaging are crucial for early detection and management.
  • Ongoing surveillance is essential for improving the quality of life and outcomes for Fontan patients.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
133
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
137
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
137
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
200
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K